| Mrs Cathy Tucker, LLPN | |
|
1653 Beach Ave, Atlantic City, NJ 08401-1607 | |
| (609) 892-2995 | |
| Not Available |
| Full Name | Mrs Cathy Tucker |
|---|---|
| Gender | Female |
| Speciality | Clinical Nurse Specialist - Medical-surgical |
| Location | 1653 Beach Ave, Atlantic City, New Jersey |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1548428865 | NPI | - | NPPES |
| 02759593 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 364SM0705X | Clinical Nurse Specialist - Medical-surgical | 181145 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Cathy Tucker, LLPN 1653 Beach Ave, Atlantic City, NJ 08401-1607 Ph: (609) 892-2995 | Mrs Cathy Tucker, LLPN 1653 Beach Ave, Atlantic City, NJ 08401-1607 Ph: (609) 892-2995 |
News Archive
Cancer has a mighty big bag of tricks that it uses to evade the body's natural defense mechanisms and proliferate. Among those tricks is one that allows tumor cells to turn the intricate and extensive system of lymphatic vessels into something of a highway to metastasis. Yet research unveiled this week may aid in the development of therapeutics that will put the brakes on such cancer spread, and the researchers who completed the study say the findings may extend to other lymphatic disorders.
Jefferson Hospital for Neuroscience is one of first medical centers in the U.S. to develop and begin using translational, interactive 3-D technology to map the human brain and help guide neurological surgeons during epilepsy surgery and procedures to remove malignant brain tumors.
Galectin Therapeutics Inc. today announced that the European Patent Office has granted the Company a new patent, No. 02731178.6, "Co-administration of a Polysaccharide with a Chemotherapy for the Treatment of Cancer".
In January 2020, the first complete severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) genome sequence was deposited to GenBank. Since then, the amount of new genome sequences has increased rapidly at GenBank and GISAID. This has laid the foundations for analyzing the virulence, antigenicity, pathogenicity, and transmissibility of SARS-CoV-2 mutations.
Necessity is the mother of invention, and nowhere does that aphorism apply more than in the realm of humans and their physical needs.
› Verified 9 days ago
Danelle Bergeron, Clinical Nurse Specialist Medicare: Medicare Enrolled Practice Location: 13 N Hartford Ave, Atlantic City, NJ 08401 Phone: 609-348-1161 Fax: 609-348-5460 |